New heart imaging device tested in small study
NCT ID NCT05931835
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested a new imaging system called VERAFEYE in 18 people already scheduled for standard heart procedures like ablation or closure. Doctors used the device during the procedure and gave feedback via a questionnaire. The goal was to gather information to improve the system, not to prove it works or is safe.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- VERAFEYE System (imaging device)
- What this could lead to
- If successful, this could help refine a new imaging tool to assist doctors during heart procedures.
- What could go wrong
- This is a very early feasibility study with only 18 people, not designed to prove safety or effectiveness. Results may not lead to a usable product.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ATRIAL ARRHYTHMIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Mater Private Network
Dublin, Leinster, D07 RD8P, Ireland
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- A tiny neck implant could catch Stroke-Causing clots before they reach the brain
- Which breathing setting keeps Kids' lungs healthier during heart surgery?
- Could a new injection tame atrial fibrillation?
- Which blood thinner is safer for heart patients? a Head-to-Head test
- Can a cholesterol drug keep atrial fibrillation at bay after ablation?
- Can a One-Two punch fix a leaky heart valve and restore normal rhythm?